From HPO
Fetal growth restriction- MedGen UID:
- 4693
- •Concept ID:
- C0015934
- •
- Pathologic Function
An abnormal restriction of fetal growth with fetal weight below the tenth percentile for gestational age.
Cholecystitis- MedGen UID:
- 920
- •Concept ID:
- C0008325
- •
- Disease or Syndrome
The presence of inflammatory changes in the gallbladder.
Cholelithiasis- MedGen UID:
- 3039
- •Concept ID:
- C0008350
- •
- Disease or Syndrome
Hard, pebble-like deposits that form within the gallbladder.
Hepatomegaly- MedGen UID:
- 42428
- •Concept ID:
- C0019209
- •
- Finding
Abnormally increased size of the liver.
Jaundice- MedGen UID:
- 43987
- •Concept ID:
- C0022346
- •
- Sign or Symptom
Yellow pigmentation of the skin due to bilirubin, which in turn is the result of increased bilirubin concentration in the bloodstream.
Erythroid hyperplasia- MedGen UID:
- 4536
- •Concept ID:
- C0014800
- •
- Disease or Syndrome
Increased count of erythroid precursor cells, that is, erythroid lineage cells in the bone marrow.
Reticulocytosis- MedGen UID:
- 60089
- •Concept ID:
- C0206160
- •
- Finding
An elevation in the number of reticulocytes (immature erythrocytes) in the peripheral blood circulation.
Chronic hemolytic anemia- MedGen UID:
- 237230
- •Concept ID:
- C1387532
- •
- Disease or Syndrome
An chronic form of hemolytic anemia.
Increased red cell osmotic fragility- MedGen UID:
- 376594
- •Concept ID:
- C1849478
- •
- Finding
Decreased hemoglobin concentration- MedGen UID:
- 1670936
- •Concept ID:
- C4732750
- •
- Finding
An abnormal reduction below normal hemoglobin concentration in the circulation.
Splenomegaly- MedGen UID:
- 52469
- •Concept ID:
- C0038002
- •
- Finding
Abnormal increased size of the spleen.
Unconjugated hyperbilirubinemia- MedGen UID:
- 82786
- •Concept ID:
- C0268306
- •
- Disease or Syndrome
An increased amount of unconjugated (indirect) bilurubin in the blood.
Reduced red cell pyruvate kinase level- MedGen UID:
- 1369680
- •Concept ID:
- C4476595
- •
- Finding
Decrease in the level of pyruvate kinase (PK) within erythrocytes. PK catalyzes the reaction
Reduced haptoglobin level- MedGen UID:
- 1686017
- •Concept ID:
- C5209264
- •
- Finding
An abnormally low concentration of haptoglobin in the blood circulation. Decreased haptoglobin in conjunction with increased reticulocyte count and anemia may indicate hemolysis. Decreased haptoglobin levels can also occur in the absence of hemolysis, due to cirrhosis of the liver, disseminated ovarian carcinomatosis, pulmonary sarcoidosis, and elevated estrogen state.
Pallor- MedGen UID:
- 10547
- •Concept ID:
- C0030232
- •
- Finding
Abnormally pale skin.
Non-immune hydrops fetalis- MedGen UID:
- 105327
- •Concept ID:
- C0455988
- •
- Disease or Syndrome
Hydrops fetalis is a descriptive term for generalized edema of the fetus, with fluid accumulation in extravascular components and body cavities. It is not a diagnosis in itself, but a symptom and end-stage result of a wide variety of disorders. In the case of immune hydrops fetalis, a frequent cause is maternofetal incompatibility as in that related to a number of genetic anemias and metabolic disorders expressed in the fetus; in other instances, it remains idiopathic and likely multifactorial (summary by Bellini et al., 2009).
Nonimmune hydrops fetalis accounts for 76 to 87% of all described cases of hydrops fetalis (Bellini et al., 2009).
Genetic Heterogeneity of Hydrops Fetalis
In southeast Asia, alpha-thalassemia (604131) is the most common cause of hydrops fetalis, accounting for 60 to 90% of cases. Almost all of these cases result from homozygous deletion of the HBA1 (141800) and HBA2 (141850) genes. A few cases have been reported that had 1 apparently normal alpha-globin gene, termed the hemoglobin H (613978) hydrops fetalis syndrome (summary by Chui and Waye, 1998).
Other genetic disorders predisposing to NIHF include other congenital anemias, such as erythropoietic porphyria (e.g., 606938.0013), and many metabolic disorders, such as one form of Gaucher disease (e.g., 606463.0009), infantile sialic acid storage disease (269920), mucopolysaccharidosis type VII (253220), glycogen storage disease IV (232500), congenital disorder of glycosylation type Ia (212065), and disorders of lymphatic malformation (see, e.g., LMPHM1, 153100).
- Abnormality of blood and blood-forming tissues
- Abnormality of metabolism/homeostasis
- Abnormality of prenatal development or birth
- Abnormality of the digestive system
- Abnormality of the immune system
- Abnormality of the integument
- Growth abnormality